logo
Plus   Neg
Share
Email

Stock Alert: Axcella Health Up 27%

Shares of Axcella Health Inc. (AXLA) jumped 27% on Friday morning after the company disclosed that Flagship Ventures has bought additional stake in the company.

AXLA is currently trading at $6.66, up $1.41 or 26.80%, on the Nasdaq.

In a regulatory filing, Axcell disclosed that on May 18, Flagship Fund IV, Flagship Fund IV-Rx and Flagship Opportunities I purchased an additional 1,52 million shares, 380 thousand shares and 1.9 million shares, respectively at $4.75 per share.

Axcella is a developer of therapies for metabolic disorders based on endogenous metabolic modulators (EMMs). Lead candidate is AXA1125 for the potential treatment of nonalcoholic steatohepatitis (NASH).

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Latam Airlines Group SA, one of the largest air carrier in South America, has filed for bankruptcy protection in New York amid the ongoing Covid-19 pandemic, which has grounded flights worldwide. This Chapter 11 filing allows Latam to work with its creditors and other stakeholders to reduce its debt,... Pizza Hut said it is giving away 500,000 free pizzas to 2020 graduates in the Unites States. The pizza chain, owned by Yum! Brands, offers one free medium 1-topping pizza to all diploma/degree earning individuals until supplies last. The company is partnering with America's dairy farmers for the offer, which can be claimed until Thursday and redeemed until June 4. Merck & Co. Inc. on Tuesday announced deals, including an acquisition and two collaborations that will enable the U.S. drugmaker to join the race to develop coronavirus vaccines and drugs. Shares of Merck were rising almost 4 percent in the pre-market. Merck said it has agreed to acquire privately-held Themis, an Austria-based company focused on vaccines and immune-modulation therapies.
Follow RTT